Last reviewed · How we verify

NCT05837702

Pain Management in Laparoscopic Cholecystectomies

Completed NA Last updated 3 May 2023
What this trial tests

NA trial testing ESPB in Nerve Block in 90 participants. Completed in 10 January 2023.

Timeline
10 January 2022
Primary endpoint
10 October 2022
10 January 2023

Quick facts

Lead sponsorGiresun University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposediagnostic
Enrollment90
Start date10 January 2022
Primary completion10 October 2022
Estimated completion10 January 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Giresun University

Who can join

18 and older, any sex, with Nerve Block. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Erector spinae plane (ESP) block is a more recent method than paravertebral block (PVB) and has a lower risk of complications. The aim of this study was to compare postoperative analgesia requirements and side-effects in terms of safely reaching the maximum analgesic effect in patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of ESPB

Trials testing the same drug.

Other recruiting trials for Nerve Block

Currently open trials in the same condition.

Other Giresun University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05837702.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing